Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs

Canadian Veterinary Journal

Volumn 47, Issue 10, 2006, Pages 999-1002

  Scott, Danny W ^a   Peters, Jeanine ^a   Miller Jr , William H ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; ENROFLOXACIN; ORBIFLOXACIN;

ARTICLE; DOG DISEASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHRODERMA; FEMALE; MALE; NONHUMAN; PATHOGENESIS; PYODERMA; RELAPSE; SPECIES DIFFERENCE; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS INTERMEDIUS; TABLET; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DOG DISEASES; DOGS; FEMALE; MALE; PYODERMA; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

CANIS FAMILIARIS; STAPHYLOCOCCUS INTERMEDIUS;

EID: 33751078290     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Scott DW, Miller WH Jr, Griffin CE. Muller & Kirk's Small Animal Dermatology VI. Philadelphia: WB Saunders, 2001:274-309.
2. Ihrke PJ, Papich MG, Demannuelle TC. The use of fluoroquinolones in veterinary dermatology. Vet Dermatol 1999;10:193-204.
3. Willis M. Orbifloxacin. Compend Contin Educ Pract Vet 2004;26: 374-378.
4. Kay-Mugford PA, Weingarten AJ, Ngoh M, et al. Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma. Vet Therap 2002;3:402-408.
5. Paradis M, Lemay S, Scott DW, Miller WH, Wellington J, Panich R. Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet Dermatol 1990;1:123-127.
6. Koch HJ, Peters S. Einsatz und Wirkung von Enrofloxacin bei bakteriellen Hauterkrankungen (Pyodermien) des Hundes. Prakt Tierärztliche 1992;73:12-18.
7. Carlotti DN, Jasmin P, Guaguère E, Thomas E. Utilisation de la marbofloxacine dans le traitement des pyodermites du chien. Prat Méd Chir Anim Comp 1995;30:281-293.
8. Carlotti DN, Guaguère E, Pin D, Jasmin P, Thomas E, Guiral V Therapy of difficult cases of canine pyoderma with marbofloxacin: A report of 39 dogs. J Small Anim Pract 1999;40:265-270.
9. Paradis M, Abbey L, Baker B, et al. Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: An open clinical trial. Vet Dermatol 2001;12:163-169.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically II. Villanova: National Committee for Clinical Laboratory Standards Document M7-A3, 1993:13-16.
11. Scott DW, Miller WH Jr, Wellington JR. The combination of ormetoprim and sulfadimethoxine in the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Canine Pract 1993;18:29-33.
12. Scott DW, Miller WH Jr, Cayatte SM, Bagladi MS. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Can Vet J 1994;35:617-621.
13. Carlotti D, Ovaert P. Utilisation de l'association amoxycilline-acide clavulanique dans le traitement de pyodermites chez le chien. Prat Méd Chir Anim Comp 1988;23:519-522.
14. Angarano DW, MacDonald JM. Efficacy of cefadroxil in the treatment of bacterial dermatitis in dogs. J Am Vet Med Assoc 1989;194: 57-59.
15. Gauguère E, Marc JP. Utilisation de la céfalexine dans le traitement des pyodermites. Prat Méd Chir Anim. Comp 1989; 24:124-129.
16. Scott DW, Beningo KE, Miller WH Jr, Rothstein E. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs. Can Vet J 1998;39:753-756.
17. Bayley AJ. Compendium of Veterinary Products VII. Port Huron: North American Compendiums, 2003: 1148-1150 (enrofloxacin), 1860-1861 (orbifloxacin), 2407-2409 (marbofloxacin).
18. Ingrey KT, Ren J, Prescott JF. A fluoroquinolone induces a novel mitogen-encoding bacteriophage in Streptococcus canis. Infect Immun 2003;71:3028-3033.